Table 1.
Group No. (n = 10) | Adjuvant | Adjuvant Dose µg/50 µL |
---|---|---|
1 | None (OVA alone) | - |
2 | SLA | 500 |
3 | R848 | 5 |
4 | CpG | 5 |
5 | MPLA | 5 |
6 | QS-21 | 5 |
7 | Pam3CSK4 | 5 |
8 | Poly(I:C) | 20 |
9 | SLA + R848 | 500 + 5 |
10 | SLA + CpG | 500 + 5 |
11 | SLA + MPLA | 500 + 5 |
12 | SLA + QS-21 | 500 + 5 |
13 | SLA + Pam3CSK4 | 500 + 5 |
14 | SLA + Poly(I:C) | 500 + 20 |